Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of exogenous surfactant in patients with lung contusions and acute lung injury

Abstract

Objective

To investigate the acute effect of surfactant replacement in multiple-trauma patients with lung contusion and acute lung injury.

Design and setting

Prospective randomized clinical trial in the 14-bed ICU of a 750-bed university hospital.

Patients and participants

Sixteen ventilated trauma patients with severe refractory hypoxemia (PaO2/FIO2 < 150 mmHg) and lung contusions.

Interventions

Patients were randomly assigned to either surfactant administration (n = 8) or standard treatment (n = 8). A single dose of natural bovine surfactant was instilled bronchoscopically in the involved lung areas; each segmental bronchus received (200/19) mg/kg body weight.

Measurements and results

The surfactant group demonstrated an acute improvement in oxygenation after surfactant replacement compared both to control group and to baseline values. In the surfactant group PaO2/FIO2 increased from 100 ± 20 mmHg at baseline to 140 ± 20 (6 h), 163 ± 26 (12 h), and 187 ± 30 mmHg (24 h). Compliance increased from 30 to 36 ml/cmH2O at 6 h after administration, and this increase remained significant at the 24, 48, and 72 h time points. The surfactant group demonstrated a higher response to recruitment maneuvers than the control group at 6 h. The mean duration of ventilatory support was 5.6 ± 2.6 days in the surfactant group and 8.1 ± 2.4 days in the control group.

Conclusions

Surfactant replacement was well tolerated in patients with lung contusions and severe hypoxemia and resulted in improved oxygenation and compliance.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Obertacke U, Neudeck F, Majetschak M, Hellinger A, Kleinschmidt C, Scade FU, Hogasen K, Jochum M, Strohmeier W, Thurnher M, Redl H, Schlag G (1998) Local and systemic reactions after lung contusion: an experimental study in the pig. Shock 10:7–12

  2. 2.

    Aufmkolk M, Fischer R, Voggenreiter G, Kleinschmidt C, Schmit-Neuerburg KP, Obertacke U (1999) Local effect of lung contusion on lung surfactant composition in multiple trauma patients. Crit Care Med 27:1441–1446

  3. 3.

    Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L (1982) Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 70:673–683

  4. 4.

    Guenther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Waimrath D, Morr H, Seeger W (1996) Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153:176–184

  5. 5.

    Nakos G, Kitsiouli E, Tsangaris I, Lekka ML (1998) Bronchoalveolar lavage fluid characteristics of early, intermediate and late phase of ARDS: alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 24:296–303

  6. 6.

    Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ (1997) Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:1309–1315

  7. 7.

    Walmrath D, Grimminger F, Pappert D, Knothe C, Obertacke U, Benzing A, Günther A, Schmehl T, Leuchte H, Seeger W (2002) Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics. Eur Respir J 19:805–810

  8. 8.

    Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte M, Richards G, Rippin G, Rathgeb F, Häfner D, Taut F, Seeger W (2004) Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351:884–892

  9. 9.

    Schulz S, Wiebalck A, Frankenberg C, Sivitanidis E, Zenz M (2000) Low-dose surfactant instillation during extracorporeal membrane oxygenation therapy in a patient with adult respiratory distress syndrome and secondary atelectasis after chest contusion. J Cardiothorac Vasc Anesth 14:59–62

  10. 10.

    Nakos G, Kitsakos A, Tsangaris H (2005) The effect of exogenous surfactant administration in patients with lung contusion. Intensive Care Med 31:S169

  11. 11.

    Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Intensive Care Med 20:225–132

  12. 12.

    MacIntyre N (2001) Evidence-based guidelines for weaning and discontinuing ventilatory support. Chest 120:375S–396S

  13. 13.

    The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308

  14. 14.

    Frerichs I, Dargaville P, van Genderingen H, Morel DR, Rimensberger PC (2006) Lung volume recruitment after surfactant administration modifies spatial distribution of ventilation. Am J Respir Crit Care Med 174:772–779

  15. 15.

    Kaam AH van, Haitsma JJ, Dik WA, Naber BA, Alblas EH, De Jaegere A, Kok JH, Lachmann B (2004) Response to exogenous surfactant is different during open lung and conventional ventilation. Crit Care Med 32:774–780

  16. 16.

    Strohmaier W, Trupka A, Pfeiler C, Thurnher M, Khakpour Z, Gippner-Steppert C, Jochum M, Redl H (2005) Bilateral lavage with diluted surfactant improves lung function after unilateral lung contusion in pigs. Crit Care Med 33:2286–2293

  17. 17.

    Dimitriou G, Greenough A, Kavadia V (1997) Changes in lung volume, compliance and oxygenation in the first 48 hours of life in infants given surfactant. J Perinat Med 25:49–54

  18. 18.

    Dinger J, Topfer A, Schaller P, Schwarze R (2002) Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome. Eur J Pediatr 161:485–490

  19. 19.

    Willson D, Thomas N, Markovitz B, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA (2005) Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 293:470–476

Download references

Author information

Correspondence to G. Nakos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tsangaris, I., Galiatsou, E., Kostanti, E. et al. The effect of exogenous surfactant in patients with lung contusions and acute lung injury. Intensive Care Med 33, 851 (2007). https://doi.org/10.1007/s00134-007-0597-z

Download citation

Keywords

  • Exogenous surfactant replacement
  • Pulmonary surfactant
  • Lung contusion
  • Acute lung injury
  • Recruitment